Skip to Main Content

Good morning, everyone, and how are you today? We are doing just fine, thank you, especially now that the Pharmalot campus has quieted down. The short person has left for the local schoolhouse — the last full day before rigorous testing begins — and the official mascots are happily snoozing below windows where a warm sun and cool breeze can be felt. As for us, yes, we are quaffing cups of stimulation, since there is much to be done and we need all the help we can get. Perhaps you can relate. Meanwhile, here are some tidbits. Have a wonderful day and please do keep in touch …

For Sen. Robert Menendez (D-N.J.), Republican challenger Bob Hugin’s record as the top Celgene (CELG) executive is fertile ground for attacks on the campaign trail. Now he just tweaked his opponent again, adding his name to legislation that Hugin fought against while at Celgene, tells us. Menendez became one of the latest co-sponsors of the CREATES Act, which is designed to make it easier for generic manufacturers to get supplies of brand-name drugs so they can produce lower-cost alternatives.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!